Back to News
Market Impact: 0.4
Boston Scientific Q3 Earnings Call Highlights
Source: marketbeat.com
Corporate EarningsCybersecurity & Data PrivacyCorporate Guidance & OutlookCompany FundamentalsAntitrust & Competition
Boston Scientific’s third-quarter 2026 results fell below prior guidance after a cybersecurity incident disrupted manufacturing and shipments for eight business days. Competitive and pricing pressures also weighed on key cardiovascular franchises.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
BSX-0.75
More News
- Truist reiterates Buy on Boston Scientific stock amid 2027 outlook
- Analysts react as Binance freezes assets after $6.3 billion security breach
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- Alphabet’s stock has worst day in over 20 years, dragging the S&P 500 to first loss in four days